November 8-10, 2021 | Virtual Conference

Register Now en English


Aloka Srinivasan, PhD

Chief Executive Officer

Aloka Srinivasan, Ph.D. is current a Principal and Managing Partner of Raaha LLC. She brings more than two decades of experience in the pharmaceutical industry, including nine years of progressive experience with the U.S. FDA in the Office of Generic Drugs and five years at National Cancer Institute. Dr. Srinivasan was the Vice President of Regulatory in Lupin Pharmaceutical Inc., Lachman Consultants Services and Principal and Parexel. During her tenure at FDA, Dr. Srinivasan was part of the team that implemented Question Based Review in OGD and spearheaded the establishment of a API review division. Dr. Srinivasan was also the representative of International Generics and Biosimilar Medicines Association (IGBA) in ICH Q11 Q&A Implementation Working Group (IWG). Dr. Srinivasan received her Ph.D. at University of Missouri, Columbia under Richard N. Loeppky of nitrosamine fame. Her thesis involved investigation of nitrosamines in cosmetics, tobacco. As a senior scientist at National Cancer Institute, she evaluated nitrosamines in potential nitric oxide donor drugs.

Get Started & Register

Whether you are an AAM member, general attendee, or exhibitor, come meet the leaders and decision-makers who are determining the future of generics and biosimilars.

Register Now

Skip to content